About the journal
Molecular Therapy: Oncolytics is an open-access journal published by Elsevier in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,900 USD. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2372-7705
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,900 USD
- Articles in DOAJ
- 805
- Declared review time
- 6 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2016-11-29
- PUBMED · 2017-03-17
- Indexing
- DOAJ · PUBMED
- APC
- 3,900 USD
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2023
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
805
Most recent article
3 years ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
827
Last recorded publication year
2023
h-index
67
i10-index
667
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2024-09-20
- Added to DOAJ
- 2016-11-29
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2024
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- Mol Ther OncolyticsMTO
- Continued by
- 2950-3299
- Source type
- journal
- NLM unique ID (PubMed)
- 101666776
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Virus-based gene therapy research
- Virus-based gene therapy research
- CAR-T cell therapy research
- CAR-T cell therapy research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
Show all subjects (50)
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Viral Infectious Diseases and Gene Expression in Insects
- Viral Infectious Diseases and Gene Expression in Insects
- Cancer Research and Treatments
- Cancer Research and Treatments
- RNA modifications and cancer
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
- Circular RNAs in diseases
- Immune Cell Function and Interaction
- Herpesvirus Infections and Treatments
- Immune Cell Function and Interaction
- Herpesvirus Infections and Treatments
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Animal Virus Infections Studies
- Animal Virus Infections Studies
- interferon and immune responses
- interferon and immune responses
- Viral gastroenteritis research and epidemiology
- Viral gastroenteritis research and epidemiology
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Nanowire Synthesis and Applications
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Nanowire Synthesis and Applications
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Cancer-related gene regulation
- Cancer-related gene regulation
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Extracellular vesicles in disease
- Extracellular vesicles in disease
- Ferroptosis and cancer prognosis
- Neuroblastoma Research and Treatments
- Ferroptosis and cancer prognosis
- Neuroblastoma Research and Treatments
Keywords (DOAJ)
- cell biology
- oncolytics
- molecular therapy
- gene therapy
- cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ